TY  - JOUR
AU  - Sarabia Vallejo, Álvaro
AU  - Caja López, María Del Mar
AU  - Olives Barba, Ana Isabel
AU  - Martín Carmona, María Antonia
AU  - Menéndez Ramos, José Carlos
PY  - 2023
DO  - 10.3390/pharmaceutics15092345
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/111911
T2  - Pharmaceutics
AB  - Many active pharmaceutical ingredients show low oral bioavailability due to factors such as poor solubility and physical and chemical instability. The formation of inclusion complexes with cyclodextrins, as well as cyclodextrin-based polymers,...
LA  - eng
M2  - 1
PB  - MDPI
KW  - Drug–cyclodextrin inclusion complexes
KW  - Nanosponges
KW  - Cyclodextrin nanofibers
KW  - Bioavailability enhancement
KW  - Cyclodextrin synthesis
KW  - Cyclodextrin analytical techniques
KW  - Anticancer drug carriers
TI  - Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects
TY  - journal article
VL  - 15
ER  -